| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Anesthesia & Analgesia, Vol 82, 13-21, Copyright © 1996 by International Anesthesia Research Society
GENERAL ARTICLES |
GJ Despotis, KS Filos, TN Zoys, CW Hogue Jr, E Spitznagel and DG Lappas
Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
The purpose of this study was to prospectively evaluate whether heparin and protamine doses administered using a standardized protocol based on body weight and activated clotting time values are associated with either transfusion of hemostatic blood products (HBPs) or excessive postoperative bleeding. Analysis using 10 multiple logistic or linear regression models in 487 cardiac surgical patients included perioperative variables that may have an association with either transfusion of HBP and/or excessive postoperative chest tube drainage (CTD). Prolonged duration of cardiopulmonary bypass (CPB), lower pre- CPB heparin dose, lower core body temperature in the intensive care unit, combined procedures, older age, repeat procedures, a larger volume of salvaged red cells reinfused intraoperatively and abnormal laboratory coagulation results (prothrombin time, activated partial thromboplastin time, and platelet count) after CPB were associated with both transfusion of HBP and increased CTD. Female gender, lower total heparin dose, preoperative aspirin use and the number of HBPs administered intraoperatively were associated only with increased CTD, whereas a larger total protamine dose was associated only with perioperative transfusion of HBPs. Preoperative use of warfarin or heparin was not associated with excessive blood loss of perioperative transfusion of HBPs. In contrast to previous studies using bovine heparin, data from the present study do not support the use of reduced doses of porcine heparin during CPB.
This article has been cited by other articles:
|
|
 |
|
  K. A. Tanaka, N. S. Key, and J. H. Levy Blood Coagulation: Hemostasis and Thrombin Regulation Anesth. Analg., May 1, 2009; 108(5): 1433 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. McIlroy, P. S. Myles, L. E. Phillips, and J. A. Smith Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis Br. J. Anaesth., February 1, 2009; 102(2): 168 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maltais, L. P. Perrault, and Q.-B. Do Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 127 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Mazer, H. Leong-Poi, J. Mahoney, D. Latter, B. H. Strauss, and J. M. Teitel Vascular Injury and Thrombotic Potential: A Note of Caution About Recombinant Factor VIIa Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2007; 11(4): 261 - 264. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Djaiani, L. Fedorko, M. A. Borger, R. Green, J. Carroll, M. Marcon, and J. Karski Continuous-Flow Cell Saver Reduces Cognitive Decline in Elderly Patients After Coronary Bypass Surgery Circulation, October 23, 2007; 116(17): 1888 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Rodrigues, P. R. B. Evora, S. Bassetto, P. M. Luciano, L. Alves Jr, A. S. Filho, and W. V. de Andrade Vicente Efficacy and Safety of Aprotinin Use for Reoperative Valvular Surgery Ann. Thorac. Surg., June 1, 2007; 83(6): 2060 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Haan, S. Milford-Beland, S. O'Brien, D. Mark, M. Dullum, T. B. Ferguson, and E. D. Peterson Impact of Residency Status on Perfusion Times and Outcomes for Coronary Artery Bypass Graft Surgery Ann. Thorac. Surg., June 1, 2007; 83(6): 2103 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Choong, C. Gerrard, K. A. Goldsmith, H. Dunningham, and A. Vuylsteke Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 834 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Sniecinski, E. P. Chen, J. H. Levy, F. Szlam, and K. A. Tanaka Coagulopathy After Cardiopulmonary Bypass in Jehovah's Witness Patients: Management of Two Cases Using Fractionated Components and Factor VIIa Anesth. Analg., April 1, 2007; 104(4): 763 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Mossad, S. Machado, and J. Apostolakis Bleeding following deep hypothermia and circulatory arrest in children. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 34 - 46. [Abstract] [PDF]
|
|
|
|
|
|
F. Filsoufi, J. G. Castillo, P. B. Rahmanian, C. Scurlock, G. Fischer, and D. H. Adams Effective Management of Refractory Postcardiotomy Bleeding With the Use of Recombinant Activated Factor VII Ann. Thorac. Surg., November 1, 2006; 82(5): 1779 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Hogue and M. J. London Aprotinin Use During Cardiac Surgery: A New or Continuing Controversy? Anesth. Analg., November 1, 2006; 103(5): 1067 - 1070. [Full Text] [PDF]
|
|
|
|
|
|
C. V. Bishop, W. E.P. Renwick, C. Hogan, M. Haeusler, A. Tuckfield, and J. Tatoulis Recombinant Activated Factor VII: Treating Postoperative Hemorrhage in Cardiac Surgery. Ann. Thorac. Surg., March 1, 2006; 81(3): 875 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pawar, Y. Mehta, A. Ansari, R. Nair, and N. Trehan Nosocomial Infections and Balloon Counterpulsation: Risk Factors and Outcome Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 316 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nurozler, T. Kutlu, G. Kucuk, and C. Okten Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 546 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dial, E. Delabays, M. Albert, A. Gonzalez, J. Camarda, A. Law, and D. Menzies Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 654 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon, S. R. Mehta, and S. F. Aranki Balancing the Benefit and Risk of Oral Antiplatelet Agents in Coronary Artery Bypass Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 768 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Poston, J. Gu, J. Manchio, A. Lee, J. Brown, J. Gammie, C. White, and B. P. Griffith Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 584 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Halkos, J. H. Levy, E. Chen, V. S. Reddy, O. M. Lattouf, R. A. Guyton, and H. K. Song Early Experience With Activated Recombinant Factor VII for Intractable Hemorrhage After Cardiovascular Surgery Ann. Thorac. Surg., April 1, 2005; 79(4): 1303 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W.A. Chu, S. R. Wilson, R. J. Novick, L. W. Stitt, and M. A. Quantz Does Clopidogrel Increase Blood Loss Following Coronary Artery Bypass Surgery? Ann. Thorac. Surg., November 1, 2004; 78(5): 1536 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Karthik, A. D. Grayson, E. E. McCarron, D. M. Pullan, and M. J. Desmond Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay Ann. Thorac. Surg., August 1, 2004; 78(2): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C R Daane, H D Golab, J H. Meeder, M J Wijers, and A J. Bogers Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume Perfusion, March 1, 2003; 18(2): 115 - 121. [Abstract] [PDF]
|
|
|
|
|
|
B. S. Donahue, D. Gailani, M. S. Higgins, D. C. Drinkwater, and A. L. George Jr Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery Circulation, February 25, 2003; 107(7): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ascione, M. Caputo, and G. D. Angelini Off-pump coronary artery bypass grafting: not a flash in the pan Ann. Thorac. Surg., January 1, 2003; 75(1): 306 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Hongo, J. Ley, S. E. Dick, and R. R. Yee The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting J. Am. Coll. Cardiol., July 17, 2002; 40(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ascione, S. Al-Ruzzeh, K. Amer, and G. D Angelini Subsystem organ function during coronary surgery Perfusion, July 1, 2002; 17(4): 295 - 303. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Skubas and G. J. Despotis Optimal Management of Bleeding Complications After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 217 - 228. [Abstract] [PDF]
|
|
|
|
|
|
C. D. Morris, J. D. Vega, J. H. Levy, N. N. Buist, A. L. Smith, G. J. Despotis, and K. R. Kanter Warfarin therapy does not increase bleeding in patients undergoing heart transplantation Ann. Thorac. Surg., September 1, 2001; 72(3): 714 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. D. Hendriks, J. M. A. A. van der Maaten, J. de Wolf, T. W. Waterbolk, M. J. H. Slooff, and J. van der Meer An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII Anesth. Analg., August 1, 2001; 93(2): 287 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Mentzelopoulos, J. N. Kokotsakis, C. N. Romana, and E. A. Karamichali Intracoronary Thrombolysis and Intraaortic Balloon Counterpulsation for the Emergency Treatment of Probable Coronary Embolism After Repair of an Acute Ascending Aortic Dissection Anesth. Analg., July 1, 2001; 93(1): 56 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ascione, S. Williams, C. T. Lloyd, T. Sundaramoorthi, A. A. Pitsis, and G. D. Angelini Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Oliver Jr, P. J. Santrach, G. K. Danielson, G. A. Nuttall, D. R. Schroeder, and M. H. Ereth Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations Ann. Thorac. Surg., December 1, 2000; 70(6): 1923 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Mahoney and J. E Donnelly Impact of closed versus open venous reservoirs on patient outcomes in isolated coronary artery bypass graft surgery Perfusion, September 1, 2000; 15(5): 467 - 472. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Levy Platelet inhibitors and bleeding in cardiac surgical patients Ann. Thorac. Surg., August 1, 2000; 70(2): S9 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Despotis and L. T. Goodnough Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery Ann. Thorac. Surg., August 1, 2000; 70(2): S20 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ascione, C. T. Lloyd, M. J. Underwood, A. A. Lotto, A. A. Pitsis, and G. D. Angelini Inflammatory response after coronary revascularization with or without cardiopulmonary bypass Ann. Thorac. Surg., April 1, 2000; 69(4): 1198 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. I. Wong, R. F. McLean, S. E. Fremes, K. A. Deemar, E. M. Harrington, G. T. Christakis, and B. S. Goldman Aprotinin and tranexamic acid for high transfusion risk cardiac surgery Ann. Thorac. Surg., March 1, 2000; 69(3): 808 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Williams, S. L. Bratton, and C. Ramamoorthy Factors Associated with Blood Loss and Blood Product Transfusions: A Multivariate Analysis in Children After Open-Heart Surgery Anesth. Analg., July 1, 1999; 89(1): 57 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Stensrud, G. A. Nuttall, M. A. de Castro, M. D. Abel, M. H. Ereth, W. C. Oliver Jr, S. C. Bryant, and H. V. Schaff A prospective, randomized study of cardiopulmonary bypass temperature and blood transfusion Ann. Thorac. Surg., March 1, 1999; 67(3): 711 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Dacey, J. J. Munoz, Y. R. Baribeau, E. R. Johnson, S. J. Lahey, B. J. Leavitt, R. D. Quinn, W. C. Nugent, J. D. Birkmeyer, G. T. O'Connor, et al. Reexploration for Hemorrhage Following Coronary Artery Bypass Grafting: Incidence and Risk Factors Arch Surg, April 1, 1998; 133(4): 442 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Despotis, J. H. Joist, and L. T. Goodnough Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes Clin. Chem., September 1, 1997; 43(9): 1684 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
